Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia
CONCLUSION: Our study revealed that the response rates of patients with AA and LD were similar to those of patients with SD to hATG combined with cyclosporine in a real-world setting.PMID:38485832 | PMC:PMC10903521 | DOI:10.1007/s44313-024-00003-z (Source: Blood Research)
Source: Blood Research - March 15, 2024 Category: Hematology Authors: Arihant Jain Aditya Jandial Thenmozhi Mani Kamal Kishore Charanpreet Singh Deepesh Lad Gaurav Prakash Alka Khadwal Reena Das Neelam Varma Subhash Varma Pankaj Malhotra Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 13:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n = 12) and Sputnik...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labben Mustpha Ferjani Hedi Gharssallah Source Type: research
Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia
CONCLUSION: Our study revealed that the response rates of patients with AA and LD were similar to those of patients with SD to hATG combined with cyclosporine in a real-world setting.PMID:38485832 | PMC:PMC10903521 | DOI:10.1007/s44313-024-00003-z (Source: Blood Research)
Source: Blood Research - March 15, 2024 Category: Hematology Authors: Arihant Jain Aditya Jandial Thenmozhi Mani Kamal Kishore Charanpreet Singh Deepesh Lad Gaurav Prakash Alka Khadwal Reena Das Neelam Varma Subhash Varma Pankaj Malhotra Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 13:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n = 12) and Sputnik...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labben Mustpha Ferjani Hedi Gharssallah Source Type: research
Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia
CONCLUSION: Our study revealed that the response rates of patients with AA and LD were similar to those of patients with SD to hATG combined with cyclosporine in a real-world setting.PMID:38485832 | PMC:PMC10903521 | DOI:10.1007/s44313-024-00003-z (Source: Blood Research)
Source: Blood Research - March 15, 2024 Category: Hematology Authors: Arihant Jain Aditya Jandial Thenmozhi Mani Kamal Kishore Charanpreet Singh Deepesh Lad Gaurav Prakash Alka Khadwal Reena Das Neelam Varma Subhash Varma Pankaj Malhotra Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 13:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n = 12) and Sputnik...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labben Mustpha Ferjani Hedi Gharssallah Source Type: research
Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia
CONCLUSION: Our study revealed that the response rates of patients with AA and LD were similar to those of patients with SD to hATG combined with cyclosporine in a real-world setting.PMID:38485832 | PMC:PMC10903521 | DOI:10.1007/s44313-024-00003-z (Source: Blood Research)
Source: Blood Research - March 15, 2024 Category: Hematology Authors: Arihant Jain Aditya Jandial Thenmozhi Mani Kamal Kishore Charanpreet Singh Deepesh Lad Gaurav Prakash Alka Khadwal Reena Das Neelam Varma Subhash Varma Pankaj Malhotra Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 13:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n = 12) and Sputnik...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labben Mustpha Ferjani Hedi Gharssallah Source Type: research
Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia
CONCLUSION: Our study revealed that the response rates of patients with AA and LD were similar to those of patients with SD to hATG combined with cyclosporine in a real-world setting.PMID:38485832 | PMC:PMC10903521 | DOI:10.1007/s44313-024-00003-z (Source: Blood Research)
Source: Blood Research - March 15, 2024 Category: Hematology Authors: Arihant Jain Aditya Jandial Thenmozhi Mani Kamal Kishore Charanpreet Singh Deepesh Lad Gaurav Prakash Alka Khadwal Reena Das Neelam Varma Subhash Varma Pankaj Malhotra Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 14;528:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n=12) and Sputn...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labbene Mustpha Ferjani Hedi Gharssallah Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 14;528:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n=12) and Sputn...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labbene Mustpha Ferjani Hedi Gharssallah Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 14;528:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n=12) and Sputn...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labbene Mustpha Ferjani Hedi Gharssallah Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 14;528:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n=12) and Sputn...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labbene Mustpha Ferjani Hedi Gharssallah Source Type: research
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
J Immunol Methods. 2024 Mar 14;528:113665. doi: 10.1016/j.jim.2024.113665. Online ahead of print.ABSTRACTOn March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine (Pfizer BioNTech and Sputnik-Gameleya V). The goal of this follow-up was to define the humoral and cellular immunological profile after immunization by assessing neutralizing antibodies and IFN- γ release. 26 vaccinated health care workers by Pfizer BioNTech (n=12) and Sputn...
Source: Journal of Immunological Methods - March 15, 2024 Category: Allergy & Immunology Authors: Nejla Stambouli Khadija Bahrini Chihebeddine Romdhani Aicha Rebai Sana Boughariou Mohamed Zakraoui Bilel Arfaoui Sameh Seyli Yasmine Boukhalfa Riadh Battikh Mohamed Ben Moussa Iheb Labbene Mustpha Ferjani Hedi Gharssallah Source Type: research
